Splash Pharmaceuticals
Series D in 2018
Splash Pharmaceuticals is a clinical-stage oncology company based in San Diego that develops novel cancer therapies. Its pipeline centers on CD44-targeting agents, including SPL-108, with activities such as anti-angiogenic and anti-metastatic effects and potential synergy with standard chemotherapy. Founded in 2001, the company aims to deliver durable responses in solid tumors and seeks partnerships to advance its programs.
Regenesis Biomedical
Series C in 2011
Regenesis Biomedical Inc. is a medical device company headquartered in Scottsdale, Arizona, specializing in the research, design, manufacture, and sale of noninvasive regenerative medicine products. Founded in 1996, the company is known for its Provant Therapy System, which utilizes an electromagnetic field to reduce pain and swelling associated with surgery and soft tissue injuries. The device serves as an adjunctive treatment option for healthcare providers, catering to various settings, including acute care hospitals, skilled nursing facilities, rehabilitation centers, and home healthcare agencies. Regenesis Biomedical aims to improve the quality of life for patients by offering effective pain management solutions without the use of drugs.
HTG Molecular Diagnostics
Series D in 2011
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
HTG Molecular Diagnostics
Series C in 2008
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software products, including CodeAssist, which automates the coding process by integrating with user operational information systems, and CodeComplete, an outsourced coding solution. Additionally, CodeRyte's DataScout tool analyzes physician narratives to extract clinically relevant information from both free-text and structured medical records. By streamlining coding processes and improving data extraction, CodeRyte enables healthcare providers to secure appropriate reimbursements, enhance compliance, and make informed treatment and business decisions. Its solutions are utilized by many prominent physician practices, billing companies, and academic medical centers across the nation, positioning CodeRyte as a vital component of their coding and data-mining operations.
Regenesis Biomedical
Series B in 2008
Regenesis Biomedical Inc. is a medical device company headquartered in Scottsdale, Arizona, specializing in the research, design, manufacture, and sale of noninvasive regenerative medicine products. Founded in 1996, the company is known for its Provant Therapy System, which utilizes an electromagnetic field to reduce pain and swelling associated with surgery and soft tissue injuries. The device serves as an adjunctive treatment option for healthcare providers, catering to various settings, including acute care hospitals, skilled nursing facilities, rehabilitation centers, and home healthcare agencies. Regenesis Biomedical aims to improve the quality of life for patients by offering effective pain management solutions without the use of drugs.
Lumidigm Inc. is a biometric technology company focused on providing secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements, enabling its sensors to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management solutions cater to various applications, including civil identification, point-of-sale systems, time and attendance tracking, and physical and logical access control. Additionally, the company offers its technology for portable electronic devices, ensuring that everyone can be accurately and conveniently identified.
AmpliMed Corporation
Series C in 2008
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.
HTG Molecular Diagnostics
Series C in 2007
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
Arxan Technologies
Series C in 2007
Arxan Technologies, Inc. is a leading provider of application protection solutions, specializing in safeguarding critical applications deployed across various platforms, including mobile devices, desktops, and embedded systems in the Internet of Things (IoT). The company offers a range of services designed to protect both source and binary code, enhancing the security perimeter for organizations. Its product lineup includes GuardIT, EnsureIT, TransformIT, and Arxan for Web, which utilize advanced technologies such as code hardening, obfuscation, white-box cryptography, and threat analytics. Arxan's solutions cater to diverse sectors, including financial services, healthcare, automotive, gaming, and e-commerce, and are designed to operate without interfering with software development processes or runtime performance. In addition to its software products, the company provides professional services, including risk assessments and protection design, aimed at ensuring comprehensive security for its clients. Founded in 2001 and headquartered in San Francisco, California, Arxan Technologies has established strategic alliances with notable firms to enhance its offerings.
Regenesis Biomedical
Series B in 2006
Regenesis Biomedical Inc. is a medical device company headquartered in Scottsdale, Arizona, specializing in the research, design, manufacture, and sale of noninvasive regenerative medicine products. Founded in 1996, the company is known for its Provant Therapy System, which utilizes an electromagnetic field to reduce pain and swelling associated with surgery and soft tissue injuries. The device serves as an adjunctive treatment option for healthcare providers, catering to various settings, including acute care hospitals, skilled nursing facilities, rehabilitation centers, and home healthcare agencies. Regenesis Biomedical aims to improve the quality of life for patients by offering effective pain management solutions without the use of drugs.
PhotoThera
Series C in 2006
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information. Specialties laser, medical device, eschemic, stroke, infrared
CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software products, including CodeAssist, which automates the coding process by integrating with user operational information systems, and CodeComplete, an outsourced coding solution. Additionally, CodeRyte's DataScout tool analyzes physician narratives to extract clinically relevant information from both free-text and structured medical records. By streamlining coding processes and improving data extraction, CodeRyte enables healthcare providers to secure appropriate reimbursements, enhance compliance, and make informed treatment and business decisions. Its solutions are utilized by many prominent physician practices, billing companies, and academic medical centers across the nation, positioning CodeRyte as a vital component of their coding and data-mining operations.
Archivas, Inc. specializes in developing scalable software solutions for archiving fixed-content data. The company's software enables customers to store, protect, and manage their data in an open and efficient online environment. Archivas focuses on facilitating compliance with internal governance and external regulations, ensuring that users have immediate access to archived data while also reducing the total cost of ownership. The Archivas Cluster (ArC) is a key component of their offering, addressing the dual needs of accessibility and cost-effectiveness in data archiving.
E Ink
Venture Round in 2005
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.
Carefx is a provider of information technology solutions tailored for healthcare organizations in North America and Europe. The company's primary offering, Fusionfx, is a suite of interoperable workflow and analytics solutions designed to streamline clinical and business processes. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating better communication between hospital and integrated delivery network executives, healthcare IT departments, and care providers. This solution enables stakeholders, including patients, payers, clinicians, and compliance agencies, to access comprehensive and understandable information, thus enhancing accountability and transparency in operations.
HTG Molecular Diagnostics
Series B in 2005
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
PhotoThera
Series B in 2005
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information. Specialties laser, medical device, eschemic, stroke, infrared
Lumidigm Inc. is a biometric technology company focused on providing secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements, enabling its sensors to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management solutions cater to various applications, including civil identification, point-of-sale systems, time and attendance tracking, and physical and logical access control. Additionally, the company offers its technology for portable electronic devices, ensuring that everyone can be accurately and conveniently identified.
Carefx is a provider of information technology solutions tailored for healthcare organizations in North America and Europe. The company's primary offering, Fusionfx, is a suite of interoperable workflow and analytics solutions designed to streamline clinical and business processes. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating better communication between hospital and integrated delivery network executives, healthcare IT departments, and care providers. This solution enables stakeholders, including patients, payers, clinicians, and compliance agencies, to access comprehensive and understandable information, thus enhancing accountability and transparency in operations.
MetaCarta
Series C in 2005
MetaCarta is a company that specializes in geographic search and referencing solutions. Its primary offering is a geographic search and referencing platform that includes components such as GeoTag, which identifies geographic references within documents. By integrating geographic search and tagging functions, MetaCarta enables users to efficiently locate information related to specific locations, enhancing the accessibility and usability of geographic data. The company's technology is designed to streamline the process of finding and referencing geographic information, making it a valuable resource for various applications in information management and analysis.
AmpliMed Corporation
Series B in 2005
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.
Protonex Technology
Series C in 2005
Protonex Technology is a developer and manufacturer of intelligent power management and portable fuel cell products tailored for military and commercial markets. The company focuses on revolutionizing portable power solutions, offering advantages over traditional batteries and generators. By providing mission-critical equipment, Protonex enhances energy efficiency and operational flexibility for military applications, addressing the evolving power needs of its users.
Protonex Technology
Series B in 2005
Protonex Technology is a developer and manufacturer of intelligent power management and portable fuel cell products tailored for military and commercial markets. The company focuses on revolutionizing portable power solutions, offering advantages over traditional batteries and generators. By providing mission-critical equipment, Protonex enhances energy efficiency and operational flexibility for military applications, addressing the evolving power needs of its users.
Archivas, Inc. specializes in developing scalable software solutions for archiving fixed-content data. The company's software enables customers to store, protect, and manage their data in an open and efficient online environment. Archivas focuses on facilitating compliance with internal governance and external regulations, ensuring that users have immediate access to archived data while also reducing the total cost of ownership. The Archivas Cluster (ArC) is a key component of their offering, addressing the dual needs of accessibility and cost-effectiveness in data archiving.
StrionAir
Series B in 2004
StrionAir Inc., established in 1987, specializes in the manufacturing of high-performance air filtration and purification systems. Their products are designed to capture and eliminate airborne pathogens, serving both residential and commercial markets. StrionAir's offerings cater to various applications such as green buildings, HVAC energy efficiency, indoor air quality improvement, healthcare facilities, and perimeter security.
Unveil Technologies
Venture Round in 2004
Unveil Technologies specializes in developing integrated customer self-service and agent-assist applications designed for contact centers. The company utilizes advanced speech and language software to enhance enterprise automation systems. Its offerings include the Meaning Recognition Engine, which optimizes the performance of both speech recognition software and live agents, as well as Conversation Manager Software, a platform that allows call center business analysts to create, deploy, and maintain voice applications effectively. Through these innovations, Unveil Technologies aims to improve customer interactions and streamline operational processes within contact centers.
AmpliMed Corporation
Series A in 2004
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.
Astoria Software
Series A in 2004
Astoria Software is a developer of content management systems focused on dynamic product documentation. The company aims to simplify the creation, management, and publication of complex business-critical content and documents. Astoria provides an integrated end-to-end solution that encompasses authoring, content management, and rendering systems, all offered as a hosted on-demand service. Through its innovative approach, Astoria Software addresses the challenges organizations face in managing essential documentation efficiently and cost-effectively.
E Ink
Venture Round in 2004
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.
Protonex Technology
Series A in 2004
Protonex Technology is a developer and manufacturer of intelligent power management and portable fuel cell products tailored for military and commercial markets. The company focuses on revolutionizing portable power solutions, offering advantages over traditional batteries and generators. By providing mission-critical equipment, Protonex enhances energy efficiency and operational flexibility for military applications, addressing the evolving power needs of its users.
MetaCarta
Series B in 2004
MetaCarta is a company that specializes in geographic search and referencing solutions. Its primary offering is a geographic search and referencing platform that includes components such as GeoTag, which identifies geographic references within documents. By integrating geographic search and tagging functions, MetaCarta enables users to efficiently locate information related to specific locations, enhancing the accessibility and usability of geographic data. The company's technology is designed to streamline the process of finding and referencing geographic information, making it a valuable resource for various applications in information management and analysis.
HTG Molecular Diagnostics
Series A in 2003
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
AmpliMed Corporation
Series A in 2003
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.
Arxan Technologies
Series B in 2003
Arxan Technologies, Inc. is a leading provider of application protection solutions, specializing in safeguarding critical applications deployed across various platforms, including mobile devices, desktops, and embedded systems in the Internet of Things (IoT). The company offers a range of services designed to protect both source and binary code, enhancing the security perimeter for organizations. Its product lineup includes GuardIT, EnsureIT, TransformIT, and Arxan for Web, which utilize advanced technologies such as code hardening, obfuscation, white-box cryptography, and threat analytics. Arxan's solutions cater to diverse sectors, including financial services, healthcare, automotive, gaming, and e-commerce, and are designed to operate without interfering with software development processes or runtime performance. In addition to its software products, the company provides professional services, including risk assessments and protection design, aimed at ensuring comprehensive security for its clients. Founded in 2001 and headquartered in San Francisco, California, Arxan Technologies has established strategic alliances with notable firms to enhance its offerings.
Carefx is a provider of information technology solutions tailored for healthcare organizations in North America and Europe. The company's primary offering, Fusionfx, is a suite of interoperable workflow and analytics solutions designed to streamline clinical and business processes. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating better communication between hospital and integrated delivery network executives, healthcare IT departments, and care providers. This solution enables stakeholders, including patients, payers, clinicians, and compliance agencies, to access comprehensive and understandable information, thus enhancing accountability and transparency in operations.
StrionAir
Series A in 2003
StrionAir Inc., established in 1987, specializes in the manufacturing of high-performance air filtration and purification systems. Their products are designed to capture and eliminate airborne pathogens, serving both residential and commercial markets. StrionAir's offerings cater to various applications such as green buildings, HVAC energy efficiency, indoor air quality improvement, healthcare facilities, and perimeter security.
Unveil Technologies
Series A in 2003
Unveil Technologies specializes in developing integrated customer self-service and agent-assist applications designed for contact centers. The company utilizes advanced speech and language software to enhance enterprise automation systems. Its offerings include the Meaning Recognition Engine, which optimizes the performance of both speech recognition software and live agents, as well as Conversation Manager Software, a platform that allows call center business analysts to create, deploy, and maintain voice applications effectively. Through these innovations, Unveil Technologies aims to improve customer interactions and streamline operational processes within contact centers.
SupplyWorks
Venture Round in 2003
SupplyWorks is a national provider of integrated facility maintenance solutions, specializing in a comprehensive range of products and services that enhance the performance, safety, and sustainability of various facilities across the United States. The company offers an extensive selection of items, including janitorial supplies, cleaning equipment, plumbing and electrical products, HVAC systems, and more. Catering to diverse sectors such as offices, educational institutions, healthcare facilities, and hospitality, SupplyWorks employs facility maintenance experts who utilize proprietary programs to deliver customized solutions tailored to the specific needs of their clients. Through their commitment to quality and service, SupplyWorks aims to improve the overall image and functionality of the facilities they support.
Lumigent Technologies
Venture Round in 2003
Lumigent Technologies specializes in providing audit and compliance solutions through its automated Governance, Risk, and Compliance software. The company's flagship product, AppGRC, is designed to reduce costs and mitigate risks associated with auditing and compliance reporting by continuously monitoring application-specific data and controls. This software safeguards business applications, ensuring the integrity of critical information while translating audit and compliance requirements for individual applications. In addition to AppGRC, Lumigent offers regulatory compliance solutions that include application risk assessments, trusted audit trails, application visibility, user management, policy violation notifications, and automated compliance reports. The company also provides Audit DB 6.2 solutions, which focus on data auditing, policy management, and database assessment, further enhancing its comprehensive approach to compliance and risk management.
CellzDirect
Venture Round in 2002
CellzDirect, Inc. is a bioscience company specializing in the provision of hepatocyte-based cell products and contract laboratory services geared towards bio/pharmaceutical companies. Founded in 2002 and headquartered in Durham, North Carolina, with a facility in Austin, Texas, the company focuses on drug metabolism and toxicology. CellzDirect supports a diverse range of clients, including pharmaceutical, biotechnology, and chemical companies, as well as academic and governmental agencies. As of January 31, 2008, CellzDirect operates as a subsidiary of Life Technologies Corporation.
HTG Molecular Diagnostics
Series A in 2002
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, specializing in precision medicine through its innovative HTG EdgeSeq platform. Established in 1997, the company offers a suite of molecular-based technology solutions for gene expression profiling and the measurement of various RNA types, including miRNA and mRNA. The HTG EdgeSeq technology automates sample processing, allowing for the rapid and simultaneous profiling of hundreds to thousands of molecular targets using minimal biological material. HTG Molecular Diagnostics markets a range of products, including instruments, assay kits, and software, which work together to facilitate efficient molecular profiling. Its offerings include several specialized panels designed for oncology and immuno-oncology applications. The company serves a diverse clientele comprising biopharmaceutical firms, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors.
E Ink
Venture Round in 2002
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.
Okena develops enterprise security software designed to protect large corporate networks from cyber threats. Its flagship product, StormWatch, focuses on application-centric technologies that monitor and enforce authorized application behavior. This proactive approach enables businesses to maintain acceptable activities while mitigating the risks of harmful actions. By integrating robust defense mechanisms, Okena aims to enhance overall network security and safeguard critical organizational assets.
Connected Corporation
Venture Round in 2001
Connected Corporation is the leading provider of storage software for automated protection, archiving and recovery of distributed data.
Sequencia
Venture Round in 2000
Sequencia offers processPoint, a web-based and collaborative Product Lifecycle Management (PLM) solution tailored for the consumer packaged goods, food and beverage, pharmaceutical, specialty chemical, and related process industries. The company specializes in supply chain management services and has developed an enterprise resource planning platform that facilitates vendor management. By integrating PLM and supply chain functionalities, Sequencia aims to enhance efficiency and collaboration within these complex industries.
I2 Technologies
Seed Round in 1996
I2 Technologies is a full-service supply chain management company that specializes in providing consulting, technology, and managed services. The company focuses on building successful partnerships with its clients, helping them achieve optimal business results. I2's solutions cater to a diverse range of industries, positioning the company as a key player in the supply chain sector. Through its comprehensive offerings, I2 Technologies aims to enhance operational efficiency and drive growth for its customers.